Cargando…

Anti-CD20 therapies in multiple sclerosis: From pathology to the clinic

The immune system plays a significant role in multiple sclerosis. While MS was historically thought to be T cell-mediated, multiple pieces of evidence now support the view that B cells are essential players in multiple sclerosis pathogenic processes. High-efficacy disease-modifying therapies that ta...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Sèze, Jérôme, Maillart, Elisabeth, Gueguen, Antoine, Laplaud, David A., Michel, Laure, Thouvenot, Eric, Zephir, Hélène, Zimmer, Luc, Biotti, Damien, Liblau, Roland
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076836/ https://www.ncbi.nlm.nih.gov/pubmed/37033984 http://dx.doi.org/10.3389/fimmu.2023.1004795

Ejemplares similares

Association Between Anti-CD20 Therapies and COVID-19 Severity Among Patients With Relapsing-Remitting and Progressive Multiple Sclerosis
por: Januel, Edouard, et al.
Publicado: (2023)

Evaluation of French-language internet sites dealing with multiple sclerosis
por: Guéguen, Antoine, et al.
Publicado: (2016)

Kappa Free Light Chain Biomarkers Are Efficient for the Diagnosis of Multiple Sclerosis: A Large Multicenter Cohort Study
por: Levraut, Michael, et al.
Publicado: (2022)

Evaluation of treatment response in adults with relapsing MOG-Ab-associated disease
por: Cobo-Calvo, Alvaro, et al.
Publicado: (2019)

Comparison of Simoa(TM) and Ella(TM) to assess serum neurofilament‐light chain in multiple sclerosis
por: Gauthier, Audrey, et al.
Publicado: (2021)

Effects of socioeconomic status on excess mortality in patients with multiple sclerosis in France: A retrospective observational cohort study
por: Wilson, Sarah, et al.
Publicado: (2022)

Mass Cytometry Identifies Expansion of T-bet(+) B Cells and CD206(+) Monocytes in Early Multiple Sclerosis
por: Couloume, Laura, et al.
Publicado: (2021)

Treatment regimens for neuromyelitis optica spectrum disorder attacks: a retrospective cohort study
por: Demuth, Stanislas, et al.
Publicado: (2022)

Excess Mortality in Patients with Multiple Sclerosis Starts at 20 Years from Clinical Onset: Data from a Large-Scale French Observational Study
por: Leray, Emmanuelle, et al.
Publicado: (2015)

Outcome and risk of recurrence in a large cohort of idiopathic longitudinally extensive transverse myelitis without AQP4/MOG antibodies
por: Maillart, Elisabeth, et al.
Publicado: (2020)

Immune Profiling Reveals the T-Cell Effect of Ocrelizumab in Early Relapsing-Remitting Multiple Sclerosis
por: Garcia, Alexandra, et al.
Publicado: (2023)

Mucosal-Associated Invariant T Cells in Multiple Sclerosis: The Jury is Still Out
por: Treiner, Emmanuel, et al.
Publicado: (2015)

Multiple sclerosis in 2020: un bon cru
por: Maillart, Elisabeth, et al.
Publicado: (2021)

Combination of attentional and spatial working memory deficits in Bálint–Holmes syndrome
por: Pisella, Laure, et al.
Publicado: (2015)

Pure Relapsing Short Myelitis: Part of the Multiple Sclerosis Spectrum or New Entity?
por: Poullet, Zélia, et al.
Publicado: (2022)

Assessing Sustained B-Cell Depletion and Disease Activity in a French Multiple Sclerosis Cohort Treated by Long-Term IV Anti-CD20 Antibody Therapy
por: Freeman, Sean A., et al.
Publicado: (2023)

Disability progression in multiple sclerosis patients using early first‐line treatments
por: Lefort, Mathilde, et al.
Publicado: (2022)

Editorial: Brain-Targeted Autoimmunity: Beyond Multiple Sclerosis
por: Nataf, Serge, et al.
Publicado: (2021)

Involvement of CD8(+) T Cells in Multiple Sclerosis
por: Salou, Marion, et al.
Publicado: (2015)

Risk Factors and Time to Clinical Symptoms of Multiple Sclerosis Among Patients With Radiologically Isolated Syndrome
por: Lebrun-Frénay, Christine, et al.
Publicado: (2021)

Patient perceptions of multiple sclerosis and its treatment
por: de Seze, Jérôme, et al.
Publicado: (2012)

Teriflunomide in Patients with Relapsing–Remitting Forms of Multiple Sclerosis
por: Chan, Andrew, et al.
Publicado: (2016)

Double-Blind Controlled Randomized Trial of Cyclophosphamide versus Methylprednisolone in Secondary Progressive Multiple Sclerosis
por: Brochet, Bruno, et al.
Publicado: (2017)

Loss of IL-10 secretion by regulatory B lymphocytes in multiple sclerosis patients
por: Michel, Laure, et al.
Publicado: (2011)

Does Fatigue Complaint Reflect Memory Impairment in Multiple Sclerosis?
por: Jougleux-Vie, Caroline, et al.
Publicado: (2014)

Commentary
por: Biotti, Damien, et al.
Publicado: (2013)

Early B cells repopulation in multiple sclerosis patients treated with rituximab is not predictive of a risk of relapse or clinical progression
por: Dorcet, Guillaume, et al.
Publicado: (2022)

MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study
por: Tourbah, Ayman, et al.
Publicado: (2016)

Beyond COVID-19: DO MS/NMO-SD patients treated with anti-CD20 therapies develop SARS-CoV2 antibodies?
por: Maillart, Elisabeth, et al.
Publicado: (2020)

Role of CD20(+) T cells in multiple sclerosis: implications for treatment with ocrelizumab
por: Gingele, Stefan, et al.
Publicado: (2019)

A meta‐analysis comparing first‐line immunosuppressants in neuromyelitis optica
por: Giovannelli, Jonathan, et al.
Publicado: (2021)

Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis
por: Laplaud, David-Axel, et al.
Publicado: (2019)

Intrathecal CD8(+)CD20(+) T Cells in Primary Progressive Multiple Sclerosis
por: von Essen, Marina Rode, et al.
Publicado: (2023)

Expanded CD8 T-cell sharing between periphery and CNS in multiple sclerosis
por: Salou, Marion, et al.
Publicado: (2015)

Metabolic Profile and Pathological Alterations in the Muscle of Patients with Early-Stage Amyotrophic Lateral Sclerosis
por: Lanznaster, Débora, et al.
Publicado: (2022)

Emotional experience is increased and emotion recognition decreased in multiple sclerosis
por: Pfaff, Line, et al.
Publicado: (2021)

Evaluation of an integrated multidisciplinary approach in multiple sclerosis care: A prospective, randomized, controlled study
por: Papeix, Caroline, et al.
Publicado: (2015)

The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells
por: Machado-Santos, Joana, et al.
Publicado: (2018)

Ocrelizumab Depletes CD20(+) T Cells in Multiple Sclerosis Patients
por: Gingele, Stefan, et al.
Publicado: (2018)

Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study
por: Vermersch, Patrick, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_q8mukqlukdamga866hmupuec6v